We spoke with Susan E. Schindler, MD, PhD, lead author of a study about the effect of race on the prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light.
For adults hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, encephalopathy at admission is the most common serious neurologic manifestation, all of which are associated with worse outcomes.
Researchers suspect patients with neurofibromatosis type 1 experience a dysregulation of melanocytogenesis, inducing abnormal polarization on both sides of RPE.
The US Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease.
Approximately 3% of patients with pneumonia associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection subsequently develop dementia.
Researchers sought to assess the qualitative effects of COVID-19 on patients with migraine who never tested positive for or been diagnosed with COVID-19.
In a retrospective descriptive study, researchers analyzed the occurrence of stroke per million doses of the COVID-19 vaccines among adult patients hospitalized during an 8-month period.
In a prospective, observational study, researchers described the differences in casemix, management, and mortality among patients undergoing emergency neurosurgery for TBI across different levels of human development.
